Mirum Pharmaceuticals Inc...
(MIRM)
undefined
undefined%
At close: undefined
42.80
0.09%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 186.37M | 77.06M | 19.14M | n/a | n/a | n/a |
| Cost of Revenue | 47.04M | 12.37M | 1.90M | 623.00K | 324.00K | n/a |
| Gross Profit | 139.34M | 64.69M | 17.23M | -623.00K | -324.00K | n/a |
| Operating Income | -109.15M | -131.22M | -173.41M | -104.30M | -54.74M | -2.92M |
| Interest Income | 13.73M | 3.86M | 366.00K | 1.56M | 2.23M | 87.00K |
| Pretax Income | -162.42M | -142.07M | -83.95M | -103.26M | -52.53M | -17.35M |
| Net Income | -163.41M | -135.66M | -83.99M | -103.27M | -52.55M | -17.35M |
| Selling & General & Admin | 145.88M | 89.07M | 59.22M | 22.69M | 11.75M | 585.00K |
| Research & Development | 102.61M | 106.84M | 131.43M | 81.61M | 42.99M | 2.33M |
| Other Expenses | n/a | 365.00K | 107.42M | -192.00K | -21.00K | n/a |
| Operating Expenses | 248.49M | 195.91M | 190.65M | 104.30M | 54.74M | 2.92M |
| Interest Expense | 15.11M | 15.98M | 17.59M | 335.00K | n/a | n/a |
| Selling & Marketing Expenses | 6.30M | 72.11M | 9.20M | n/a | n/a | -292.50K |
| Cost & Expenses | 295.53M | 208.28M | 192.55M | 104.30M | 54.74M | 2.92M |
| Income Tax | 991.00K | -6.41M | 37.00K | 6.00K | 21.00K | -4.37M |
| Shares Outstanding (Basic) | 40.89M | 33.84M | 30.32M | 25.25M | 22.99M | 22.99M |
| Shares Outstanding (Diluted) | 40.89M | 33.84M | 30.32M | 25.25M | 22.99M | 22.99M |
| EPS (Basic) | -4 | -4.01 | -2.77 | -4.09 | -2.29 | -0.75 |
| EPS (Diluted) | -4 | -4.01 | -2.77 | -4.09 | -2.29 | -0.75 |
| EBITDA | -136.49M | -122.41M | -65.39M | -102.31M | -52.21M | -17.33M |
| Depreciation & Amortization | 10.83M | 3.68M | 975.00K | 623.00K | 324.00K | 4.37M |